CRISPR/Cas9 system: A promising technology for the treatment of inherited and neoplastic hematological diseases-Reference-Cited by-同舟云学术

CRISPR/Cas9 system: A promising technology for the treatment of inherited and neoplastic hematological diseases

Published:2018-05 Issue:1 Volume:1 Page:e10
ISSN:2573-8461
Container-title:Advances in Cell and Gene Therapy
language:en
Short-container-title:Adv Cell Gene Ther

Author:

Antony Justin S.¹²³^ORCID,Haque A.K.M. Ashiqul¹,Lamsfus-Calle Andrés²,Daniel-Moreno Alberto²,Mezger Markus²,Kormann Michael S.D.¹^ORCID

Affiliation:

1. Department of Pediatrics I; Pediatric Infectiology and Immunology; Translational Genomics and Gene Therapy in Pediatrics; University of Tübingen; Tübingen Germany

2. University Children's Hospital; Department of Paediatrics I, Hematology and Oncology; University of Tübingen; Tübingen Germany

3. Department of Hematology, Oncology; Clinical Immunology; University of Tübingen; Tübingen Germany

Funder

Jürgen Manchot Stiftung

H2020 European Research Council

Medizinischen Fakultät, Eberhard Karls Universität Tübingen

Publisher

Hindawi Limited

Reference88 articles.

1. Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency;De Ravin;Sci Transl Med,2016

2. Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy;Eichler;N Engl J Med,2017

3. Gene therapy of the beta-hemoglobinopathies by lentiviral transfer of the beta(A(T87Q))-globin gene;Negre;Hum Gene Ther,2016

4. Efficient ex vivo engineering and expansion of highly purified human hematopoietic stem and progenitor cell populations for gene therapy;Zonari;Stem Cell Reports,2017

5. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia;Cavazzana-Calvo;Nature,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR-CAS9-MEDIATED EX VIVO GENE EDITING FOR INHERITED HEMATOLOGICAL DISORDERS: ADVANCEMENTS, CHALLENGES, AND CLINICAL POTENTIAL;International Journal of Pharmacy and Pharmaceutical Sciences;2024-09-01

2. CRISPR medicine for blood disorders: Progress and challenges in delivery;Frontiers in Genome Editing;2023-01-06

3. The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases;Frontiers in Cell and Developmental Biology;2021-12-15

4. A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy;The CRISPR Journal;2021-12-08

5. Diversification of the CRISPR Toolbox: Applications of CRISPR-Cas Systems Beyond Genome Editing;The CRISPR Journal;2021-06-01